Ms. Healey said the settlement was over allegations that OptumRx skipped over regulatory benchmarks for pricing workers’ compensation prescription drug charges.
By skipping over the regulatory process, OptumRx allowed “excessive drug costs” to be unjustly passed on to the workers’ compensation insurance system, according to the announcement.
“Our investigation found that OptumRx drove up costs in the system, which can increase premiums for small business owners across the state, many of whom have been struggling during the COVID pandemic,” Healey said. “This settlement ensures that OptumRx does not unlawfully profit and follows the rules going forward.”
OptumRx will also be required by the settlement to shore up its processes to ensure no other overcharges affect the workers’ compensation system.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
